Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 4
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 2, 2006
Restless leg syndrome: is it a real problem?
Paul E Cotter, Shaun T O’Keeffe
Therapeutics and Clinical Risk Management 2006, 2:465-475
Published Date: 15 December 2006
Update on the appropriate use of linezolid in clinical practice
Roberto Manfredi
Therapeutics and Clinical Risk Management 2006, 2:455-464
Published Date: 15 December 2006
Optimizing use of opiates in the management of cancer pain
Mario Mandalà, Cecilia Moro, Roberto Labianca, Marco Cremonesi, Sandro Barni
Therapeutics and Clinical Risk Management 2006, 2:447-453
Published Date: 15 December 2006
Role of erlotinib in the management of pancreatic cancer
Naureen Starling, John Neoptolemos, David Cunningham
Therapeutics and Clinical Risk Management 2006, 2:435-445
Published Date: 15 December 2006
Moxifloxacin in the treatment of skin and skin structure infections
David RP Guay
Therapeutics and Clinical Risk Management 2006, 2:417-434
Published Date: 15 December 2006
Meropenem in the treatment of complicated skin and soft tissue infections
Douglas N Fish
Therapeutics and Clinical Risk Management 2006, 2:401-415
Published Date: 15 December 2006
Infliximab (Remicade) in the treatment of psoriatic arthritis
Philip Mease
Therapeutics and Clinical Risk Management 2006, 2:389-400
Published Date: 15 December 2006
Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
Kavita Raj, Ghulam J Mufti
Therapeutics and Clinical Risk Management 2006, 2:377-388
Published Date: 15 December 2006
Abatacept in the treatment of rheumatoid arthritis
Edward M Vital, Paul Emery
Therapeutics and Clinical Risk Management 2006, 2:365-375
Published Date: 15 December 2006
In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technologic advancement
Jeff Wang, Mark V Sauer
Therapeutics and Clinical Risk Management 2006, 2:355-364
Published Date: 15 December 2006
House dust mite control measures in the treatment of asthma
Gillian Vallance, Charles McSharry, Stuart Wood, Neil C Thomson
Therapeutics and Clinical Risk Management 2006, 2:347-354
Published Date: 15 December 2006
Brimonidine in the treatment of glaucoma and ocular hypertension
Louis B Cantor
Therapeutics and Clinical Risk Management 2006, 2:337-346
Published Date: 15 December 2006
Editorial ||FREE PAPER||
Garry Walsh
Therapeutics and Clinical Risk Management 2006, 2:335-336
Published Date: 15 December 2006